Interim report January 1 – March 31, 2026

Q1 2026 earnings improved, with operating profit rising to SEK 37m from SEK 12m and the period result turning to SEK 32m from a SEK 150m loss. Operating margin expanded to 3.2% from 1.1%, while basic EPS improved to SEK 2.18 from -SEK 10.32. Revenue fell 6% to SEK 1,128m, but the profit and margin recovery point to continued operational progress.

Analysis

The key read-through is not “revenue down, profits up,” but that management is showing operating leverage in a soft-demand tape. That usually signals either a better product mix, tighter cost control, or both — and in each case the next leg tends to come from pricing discipline rather than volume recovery. If that discipline is real, smaller and less efficient competitors will feel it first because they lack the margin buffer to absorb lower top-line growth without cutting price or spending.

The second-order effect is on the supplier ecosystem: when a company can defend margin on lower revenue, it typically means procurement, logistics, or labor inputs are being renegotiated harder. That shifts pain downstream to vendors with weak balance sheets and can create a delayed earnings reset over the next 1–2 quarters as those counterparties either lose share or demand better terms. The market often underestimates how persistent this can be once management proves it can protect profitability in a downcycle.

The main risk is that this is a margin peak, not a new run-rate. If the improvement came from temporary cost actions, working-capital discipline, or one-time mix benefits, the next earnings reports could flatten quickly even if cash generation stays decent. The catalyst window is the next 1–2 quarters: if revenue keeps shrinking while profits hold, the stock can rerate higher on quality-of-earnings; if revenue stabilizes but margins compress, the move reverses fast.

Contrarian angle: the consensus will likely focus on the improving profit line and miss that lower revenue can actually be a warning sign of share loss or weaker end-demand. In that case, the current optimism may be underpriced if the market is extrapolating margin resilience without proof of demand recovery. I would treat this as a stock-specific credibility test: evidence of durable pricing power is bullish, but evidence of volume weakness beneath the surface argues for fading the rally rather than chasing it.

Key Decisions for Investors

• If this is a listed industrial/consumer business with peers, favor a long/short pair: long the name versus a higher-cost rival with weaker margins, but only on confirmation that gross margin expansion is repeatable over the next 1-2 quarters. Risk/reward is best if entry is after the next print confirms no margin giveback.
• Buy short-dated calls or a call spread only into the next earnings release if the stock has not yet rerated on the margin surprise; the setup is a 4-8 week momentum trade, not a multi-quarter conviction buy, unless revenue stabilizes.
• If you own the stock, consider monetizing part of the move with a covered call against the next 1-2 months of implied volatility. The asymmetry is that good margin news can continue, but the first disappointment will likely come from the top line, not the bottom line.
• For event-driven accounts, watch supplier and competitor names for weakness over the next 30-60 days: a profitable company holding margin on falling revenue often foreshadows margin compression in the weaker second-tier players first.
• Avoid extrapolating this into a full-year growth story until the next quarter provides evidence that cash flow quality is improving alongside revenue. If revenue keeps downshifting, a fade-on-strength trade becomes attractive on any post-earnings pop.